OptimizeRx (OPRX) Income from Non-Controlling Interests (2021 - 2023)
OptimizeRx's (OPRX) quarterly Income from Non-Controlling Interests came in at -$4.2 million in Q2 2023, down 7.12% year-on-year from -$4.5 million in Q2 2022, and up 34.95% quarter-over-quarter from -$6.4 million in Q1 2023.
OptimizeRx (OPRX) Income from Non-Controlling Interests (2021 - 2023) Analysis & Trends
OptimizeRx has disclosed Income from Non-Controlling Interests across 3 years of filings, most recently posting -$4.2 million for Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 26.11 Bn | 18.79 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 12.95 Bn | 12.07 Bn | 482.22 Mn | -157,000.00 |
| 3 | Healthequity | 7.46 Bn | 7.19 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 5.15 Bn | 4.83 Bn | 154.23 Mn | - |
| 5 | Doximity | 3.75 Bn | 3.00 Bn | 125.97 Mn | - |
| 6 | 10x Genomics | 3.69 Bn | 3.15 Bn | 106.18 Mn | - |
| 7 | Waystar Holding | 3.61 Bn | 3.45 Bn | 268.04 Mn | - |
| 8 | Privia Health | 2.90 Bn | 2.54 Bn | 595.71 Mn | 646,000.00 |
| 9 | Omnicell | 1.72 Bn | 1.54 Bn | 140.36 Mn | - |
| 10 | OptimizeRx | 97.75 Mn | 77.58 Mn | 15.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -4.16 Mn |
| Mar 31, 2023 | -6.40 Mn |
| Sep 30, 2022 | -3.47 Mn |
| Jun 30, 2022 | -3.88 Mn |
| Mar 31, 2022 | -3.76 Mn |
| Sep 30, 2021 | 39,894.00 |
| Jun 30, 2021 | 352,100.00 |